| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |